PBH
PBH
NYSE · Pharmaceuticals

Prestige Consumer Healthcare

$54.85
+0.42 (+0.77%)
As of Aug 8, 1:30 AM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +42.5% upside
Low Target $50.25
Average Target $78.15
High Target $108.25
Current Price $54.85
Current
$54.85
Target
$78.15
$50.25 $78.15 avg $108.25
Scenario Analysis
Bear Case
$50.25
-8.4%
Low target
Base Case
$78.15
+42.5%
Avg target
Bull Case
$108.25
+97.4%
High target
Risk/Reward
11.6x
Highly favorable
Price in Context
52-Week High
$75.31
-27.2% from high
52-Week Low
$42.62
+28.7% from low
50-Day SMA
$64.04
-14.4% vs SMA
200-Day SMA
$69.15
-20.7% vs SMA
RSI (14)
68.6
Neutral
Target vs 52W High
$78.15
+3.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%